Karyopharm Therapeutics Inc. ($KPTI)
Abate Kristin โ Chief Accounting Officer
Shares
559
Price
$9.41
Total Value
$5,259.91
Nearby Earnings
Feb 18, 2026
EPS:Est: -2.26
Revenue:Est: $33.16M
Transaction Details
| Insider | Abate Kristin |
|---|---|
| Title | Chief Accounting Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 559 |
| Price per Share | $9.41 |
| Total Value | $5,259.91 |
| Shares Owned After | 22,063 |
| Derivative | No |
| Accession Number | 0002045943-26-000003 |
| Document | View SEC Filing |